VCVictor Hugo Oliveira Martins Coelho

Victor Hugo Oliveira Martins Coelho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victor Hugo Oliveira Martins Coelho has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perfil epidemiológico das neoplasias malignas da próstata no Brasil - Descrição de meia década e a influência da pandemia de SARS-CoV-2

    by Marianna Silva Dezembro Leonelo, João Pedro Oliveira Rezende, Pedro Henrique e Silva Álvaro, Luana Marcelino Mattos Araújo, José Diogo Pereira Cantarelli, Victor Oliveira Martins Coelho, Pedro Henrique Martins de Oliveira

    El cáncer de próstata (CP) es el segundo más común en los hombres. En comparación con otras neoplasias malignas, las disparidades regionales y étnicas siguen siendo un problema. El cribado se realiza mediante la medición del antígeno prostático específico (PSA) y el tacto rectal y, si es necesario, una biopsia. Existe controversia sobre el beneficio del cribado anual. Dada la importancia de los estudios epidemiológicos, este estudio tuvo como objetivo cuantificar los casos notificados y describir factores relacionados con la tasa de mortalidad y el número de internaciones por CP entre los años 2018 y 2023. Los datos fueron obtenidos del Departamento de Tecnología de la Información del SUS (DATASUS), ICD10 -C61 (neoplasia maligna de próstata) por lugar de residencia. La población estudiada son hombres de 40 años o más. La epidemiología en Brasil es similar a la de los países desarrollados, a pesar de las disparidades regionales. Se produjeron más hospitalizaciones en el sureste y menos en el norte, junto con la tasa gde mortalidad más alta. Las desigualdades entre Regiones se deben al acceso desigual del Estado. Existe predominio en la tasa de mortalidad a los 80 años o más y mayor número de hospitalizaciones a los 60 a 69 años. Las personas mestizas tuvieron un mayor número de hospitalizaciones. La tasa de mortalidad más alta se produjo en 2021 y el mayor número de hospitalizaciones en 2022 y 2023, lo que puede estar influenciado por la pandemia de SARS-CoV-2. Analizar el perfil de esta neoplasia es fundamental para orientar la planificación de políticas públicas, lo que requiere medidas para brindar un acceso más equitativo a los establecimientos de salud. Prostate cancer (PC) is the 2nd most common in men. When compared with other malignancies, regional and ethnic disparities remain a problem. Screening is carried out through prostate specific antigen (PSA) measurement and digital rectal exam, and, if necessary, biopsy. There is controversy regarding the benefit of annual screening. Given the importance of epidemiological studies, this study aimed to quantify reported cases and describe factors related to the mortality rate and number of hospitalizations for PC between the years 2018 and 2023. The data were obtained from the SUS Information Technology Department (DATASUS), ICD10-C61 (malignant neoplasm of the prostate) by place of residence. The population studied are men aged 40 or over. Epidemiology in Brazil is like developed countries, despite regional disparities. More hospitalizations occurred in the Southeast and fewer in the North, along with the highest mortality rate. Inequalities between Regions are due to unequal access by the State. There is a predominance in the mortality rate at 80 years of age or more and a greater number of hospitalizations at 60 to 69 years of age. Mixed race people had a higher number of hospitalizations. The highest mortality rate occurred in 2021 and the highest number of hospitalizations in 2022 and 2023, which may be influenced by the SARS-CoV-2 pandemic. Analyzing the profile of this neoplasm is essential to guide the planning of public policies, requiring measures to provide more equitable access to health facilities. O câncer de próstata (CP) é o 2º mais comum em homens. Quando comparado com outros tumores malignos, as disparidades regionais e étnicas continuam a ser uma problemática. O rastreio é realizado através da dosagem de antígeno específico da próstata (PSA) e toque retal, e, se necessário, biópsia. Existem controvérsias em relação ao benefício do rastreamento anual. Dada à importância dos estudos epidemiológicos, este estudo teve como objetivo quantificar os casos notificados e descrever fatores relacionados à taxa de mortalidade e número de internações por CP entre os anos de 2018 e 2023. Os dados foram obtidos no Departamento de Informática do SUS (DATASUS), CID10-C61 (neoplasia maligna da próstata) por local de residência. A população estudada é composta por homens com 40 anos ou mais. A epidemiologia no Brasil se assemelha aos países desenvolvidos, apesar das disparidades regionais. Mais internações ocorreram no Sudeste e menos no Norte, junto com a maior taxa de mortalidade. As desigualdades entre as Regiões são devido a desigualdade de acesso do Estado. Há predominância na taxa de mortalidade aos 80 anos ou mais e maior número de internações aos 60 a 69 anos. Os pardos obtiveram maior número de internação. A maior taxa de mortalidade ocorreu no ano de 2021 e o maior número de internações em 2022 e 2023, podendo ser influenciado pela pandemia de SARS-CoV-2. Analisar o perfil dessa neoplasia é fundamental para direcionar o planejamento das políticas públicas, necessitando de medidas para propiciar acesso mais equitativo às instalações de saúde.


  • Open Access

    Eficácia da pimavanserina para pacientes com psicose na doença de Parkinson: Uma revisão sistemática

    by Rayanne da Cunha Mendes, Sâmara Pesqueira Souza, Luis Claudio Almeida da Silva Junior, Jordy Silva de Carvalho, Victor Hugo Oliveira Martins Coelho, Wagner Gonçalves Horta

    The present study aims to evaluate the effectiveness of pimavanserin in patients with psychosis in Parkinson's disease. Its effects on the clinical picture of psychosis were evaluated, as well as its adverse reactions and influences on patients' quality of life. This is a Systematic Literature Review of a qualitative nature, with a search strategy for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Critical Appraisal Skill Program (CASP) methodological evaluation, analyzing a total of 8 articles. Articles were searched in PubMed databases, excluding simple literature reviews and incomplete articles. Those published in the last 10 years (2013-2023) and available in English were included. After a systematic analysis of the studies, it is concluded that pimavanserin demonstrates effectiveness in reducing hallucinogenic and delusional symptoms. Furthermore, it was found that the combination of pimavanserin with other medications, especially clozapine, showed promise in terms of safety, especially in improving cognitive functions. Patients showed improvements in the quality of sleep and wakefulness, in addition to a significant reduction in symptoms. Furthermore, side effects include pneumonia, episodes of syncope, obstructive pulmonary disease, pulmonary embolism and deep vein thrombosis. It is expected that future studies will continue to develop more intervention research on the effectiveness of the medication in treating Parkinson's disease, highlighting benefits and improvements in patients' quality of life through the use of the drug in medical practice.


  • Open Access

    A dieta cetogênica como intervenção para melhoria da qualidade de vida em pacientes diagnosticados com Síndrome de West: Uma revisão sistemática

    by Rayanne da Cunha Mendes, Sâmara Pesqueira Souza, Luis Claudio Almeida da Silva Junior, Jordy Silva de Carvalho, Victor Hugo Oliveira Martins Coelho, Wagner Gonçalves Horta

    The present study aims to evaluate the effectiveness of the ketogenic diet in improving the quality of life of patients with West Syndrome, in the control of spasms and convulsions, the benefits of its use alone and as an adjunct to conservative therapies, and its short-term consequences. and long term regarding its tolerance and side effects. This is a Systematic Literature Review of a qualitative nature, with a search strategy for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Critical Appraisal Skill Program (CASP) methodological evaluation, analyzing a total of 6 articles. The articles were searched in the PubMed and SciELO databases, excluding simple literature reviews. Articles published in the last 10 years (2013-2023) and available in English were included. After a systematic analysis of the studies, it appears that the ketogenic diet is effective in reducing infantile spasms, especially in cases refractory to combined drug treatments. In addition, the side effects and relapses to the condition were lower than in patients who used adrenocorticotropic hormone. The Atkins diet approach has also been successful in stopping spasms. The ketogenic diet was well tolerated, with minimal side effects when combined with Vigabatrin. Side effects included increased triglycerides and ketone body. It is hoped that future studies will continue to highlight the benefits and improvements in the quality of life of patients with West Syndrome.